SYDNEY, May 20, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products ...

"The Launch-HTN trial is the largest Phase III hypertension study with a novel drug. We tested lorundrostat in a large, diverse patient population recruited globally, and found that it has a good ...

Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEER™-IPF and FIBRONEER™-ILD, significantly reducing the decline in forced vital capacity (FVC ...

Backers of Jena, Germany-based Inflarx NV have turned their attention to the rest of the pipeline after the stock-jolting news from an independent data monitoring committee (DMC) responsible for the ...

Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER™-IPF and FIBRONEER™-ILD trials. These studies evaluated nerandomilast, an investigational oral, preferential ...

SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold ...

New post-hoc analyses from the investigational Phase III ARANOTE trial showed a clinically meaningful improvement in health-related quality of life (HRQoL) and delayed pain progression for ...

Or sign-in if you have an account. OTTAWA — King Charles III concluded a historic address in Ottawa on Tuesday by quoting words of the Canadian anthem. “The True North is indeed strong and ...

WNBA Fans in Disbelief Over Angel Reese's Pass originally appeared on Athlon Sports. During her first year in the WNBA, Angel Reese dished out 1.9 assists per game. Playmaking isn't really her ...